| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| Cost of Revenue | $576K | -25.8% | -64.4% |
| R&D Expense | $328K | +11.2% | -17.6% |
| SG&A Expense | $2.1M | -2.7% | -22.3% |
| Operating Income | -$3.1M | +56.4% | +41.2% |
| Pre-tax Income | -$3.1M | +53.9% | +40.1% |
| Net Income | -$3.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.6M | +85.5% | +21.6% |
| Inventory | $244K | -0.4% | -26.1% |
| Current Assets | $4.0M | +67.5% | -4.7% |
| Total Assets | $10.5M | +13.6% | -63.1% |
| Current Liabilities | $3.5M | -4.8% | -51.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.6M | — | — |
| Capital Expenditures | $421K | — | — |
| Investing Cash Flow | $5.0M | — | — |
| Financing Cash Flow | $2.2M | — | — |
| Free Cash Flow | -$8.1M | — | — |
| +40.1% |
| EPS (Basic) | -$2.19 | +70.6% | -188.2% |
| $4.0M |
| -3.5% |
| -47.5% |
| Stockholders' Equity | $6.5M | +27.4% | -68.8% |